Posted by Michael Wonder on 12 Sep 2023
The Inflation Reduction Act will lead to fewer new medicines
11 September 2023 - The impact of the Inflation Reduction Act on the biopharmaceutical industry is going to be substantial in a number of ways.
Already companies are analysing the strategies for the types of programs that they work on in light of the coming price controls.
